George Kemble
Chairman chez SAGIMET BIOSCIENCES INC.
Fortune : 847 580 $ au 31/03/2024
Profil
George W.
Kemble is currently the Executive Chairman at Sagimet Biosciences, Inc. He previously worked as a Director at LigoCyte Pharmaceuticals, Inc., a Senior Vice President-Research & Development at MedImmune LLC, and a Staff Scientist at MedImmune Vaccines, Inc. He holds a doctorate degree from Stanford University and an undergraduate degree from Santa Clara University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/11/2023 | 156 380 ( 0,73% ) | 847 580 $ | 31/03/2024 |
Postes actifs de George Kemble
| Sociétés | Poste | Début |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Chairman | 24/10/2022 |
Anciens postes connus de George Kemble
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | - |
| LigoCyte Pharmaceuticals, Inc. | Director/Board Member | - |
Formation de George Kemble
| Stanford University | Doctorate Degree |
| Santa Clara University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
| LigoCyte Pharmaceuticals, Inc. | Health Technology |
